Shaun Noorian

And so you can get a much different pharmacokinetic response and peak than you would be able to by just utilizing a single ester by itself.

And so you can get a much different pharmacokinetic response and peak than you would be able to by just utilizing a single ester by itself.

And so you can get a much different pharmacokinetic response and peak than you would be able to by just utilizing a single ester by itself.

Yeah, it's a good question. You know, compounding pharmacies, as I mentioned, they've been around since the beginning of time. And they've been around before big pharma was around. And they're governed by the state boards of pharmacy, as well as the FDA.

Yeah, it's a good question. You know, compounding pharmacies, as I mentioned, they've been around since the beginning of time. And they've been around before big pharma was around. And they're governed by the state boards of pharmacy, as well as the FDA.

Yeah, it's a good question. You know, compounding pharmacies, as I mentioned, they've been around since the beginning of time. And they've been around before big pharma was around. And they're governed by the state boards of pharmacy, as well as the FDA.

And the rules around making drugs, especially drugs that are destined to be injected into people, they are some of the strictest rules of any industry. And so state boards, they inspect compounding pharmacies every single year. And, uh,

And the rules around making drugs, especially drugs that are destined to be injected into people, they are some of the strictest rules of any industry. And so state boards, they inspect compounding pharmacies every single year. And, uh,

And the rules around making drugs, especially drugs that are destined to be injected into people, they are some of the strictest rules of any industry. And so state boards, they inspect compounding pharmacies every single year. And, uh,

ensure that the rules that are primarily the United States Pharmacopeia, the standard setting organization for all drugs that are made in pharmacies, the rules that they set are being abided by.

ensure that the rules that are primarily the United States Pharmacopeia, the standard setting organization for all drugs that are made in pharmacies, the rules that they set are being abided by.

ensure that the rules that are primarily the United States Pharmacopeia, the standard setting organization for all drugs that are made in pharmacies, the rules that they set are being abided by.

And then of course the FDA got jurisdiction of the practice of pharmacy in 2013 with the passage of the Drug Quality Security Act because of that fungal meningitis outbreak that happened in 2012 from a company called NECC or New England Compounding Centers. And that pharmacy made one bad batch, or I should say three bad batches, and killed 70 people and injured 700 or more.

And then of course the FDA got jurisdiction of the practice of pharmacy in 2013 with the passage of the Drug Quality Security Act because of that fungal meningitis outbreak that happened in 2012 from a company called NECC or New England Compounding Centers. And that pharmacy made one bad batch, or I should say three bad batches, and killed 70 people and injured 700 or more.

And then of course the FDA got jurisdiction of the practice of pharmacy in 2013 with the passage of the Drug Quality Security Act because of that fungal meningitis outbreak that happened in 2012 from a company called NECC or New England Compounding Centers. And that pharmacy made one bad batch, or I should say three bad batches, and killed 70 people and injured 700 or more.

And so the FDA, so Congress then came in and said, how can we prevent this from happening again? And that is how the Drug Quality Security Act was passed. And this new category of 503B outsourcing facilities was created where the drugs that come from these facilities are made under good manufacturing practices or CGMPs, the same standards that the pharmaceutical industry uses.

And so the FDA, so Congress then came in and said, how can we prevent this from happening again? And that is how the Drug Quality Security Act was passed. And this new category of 503B outsourcing facilities was created where the drugs that come from these facilities are made under good manufacturing practices or CGMPs, the same standards that the pharmaceutical industry uses.

And so the FDA, so Congress then came in and said, how can we prevent this from happening again? And that is how the Drug Quality Security Act was passed. And this new category of 503B outsourcing facilities was created where the drugs that come from these facilities are made under good manufacturing practices or CGMPs, the same standards that the pharmaceutical industry uses.

You know, company pharmacies, you know, one – People, a lot of prescribers prefer to use a compounding pharmacy for a patient because they can be assured that they are getting exactly what the doctor ordered. What strength is labeled on that vial will be what that strength should be because of all the rules and regulations around the practice of compounding and manufacturing drugs in this country.

You know, company pharmacies, you know, one – People, a lot of prescribers prefer to use a compounding pharmacy for a patient because they can be assured that they are getting exactly what the doctor ordered. What strength is labeled on that vial will be what that strength should be because of all the rules and regulations around the practice of compounding and manufacturing drugs in this country.